Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Determine the serum pharmacokinetic profile for two oral formulations of T-esters (one TE and
one TU) administered once -(QD) and twice-daily (BID) to hypogonadal men.
Phase:
Phase 2
Details
Lead Sponsor:
Clarus Therapeutics, Inc.
Collaborators:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center